A Inbal Selected Research

Primary Myelofibrosis (Myelosclerosis)

5/2001

Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Inbal Research Topics

Disease

4	Thrombosis (Thrombus) 07/2008 - 01/2000
3	Hemorrhage 01/2017 - 07/2008
1	von Willebrand Diseases (von Willebrand's Disease) 01/2016
1	Wounds and Injuries (Trauma) 03/2013
1	Afibrinogenemia (Fibrinogen Deficiency) 07/2008
1	Type 1 von Willebrand Disease 05/2008
1	Factor XIII Deficiency 10/2004
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2004
1	Thrombophilia 09/2004
1	Habitual Abortion (Recurrent Miscarriage) 03/2003
1	hereditary Thrombophilia 03/2003
1	Carotid Stenosis (Carotid Artery Stenosis) 12/2001
1	Leukemia 11/2001
1	Neoplasms (Cancer) 11/2001
1	Lymphoma (Lymphomas) 11/2001
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2001
1	Primary Myelofibrosis (Myelosclerosis) 05/2001
1	Venous Thromboembolism 01/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2000
1	Carotid Artery Thrombosis 11/2000
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 11/2000
1	Ischemic Stroke 06/2000
1	Protein S Deficiency (Deficiency, Protein S) 06/2000
1	Antithrombin III Deficiency 06/2000

Drug/Important Bio-Agent (IBA)

2	Fibrinogen (Factor I)FDA Link 07/2008 - 09/2004
2	Proteins (Proteins, Gene)FDA Link 07/2008 - 11/2001
2	von Willebrand FactorIBA 05/2008 - 11/2000
2	Protein SIBA 09/2004 - 06/2000
2	HomocysteineIBA 09/2004 - 12/2001
2	Protein CIBA 09/2004 - 06/2000
2	AntithrombinsIBA 09/2004 - 06/2000
2	Prothrombin (Factor II)IBA 12/2001 - 06/2000
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2001 - 01/2001
2	factor V LeidenIBA 12/2001 - 06/2000
2	Antiphospholipid AntibodiesIBA 12/2001 - 06/2000
1	Hemostatics (Antihemorrhagics)IBA 01/2017
1	von Willebrand factor drug combination factor VIIIIBA 01/2016
1	AntibodiesIBA 12/2014
1	Polystyrenes (Polystyrene)IBA 03/2013
1	FibrinIBA 07/2008
1	Phospholipids (Phosphatides)FDA LinkGeneric 07/2008
1	Blood Coagulation Factors (Coagulation Factor)IBA 07/2008
1	Factor XIII (Coagulation Factor XIII)IBA 10/2004
1	Thymidine Monophosphate (TMP)IBA 09/2004
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 09/2004
1	antithrombin III-protease complexIBA 09/2004
1	CD40 Ligand (CD40L)IBA 09/2004
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2003
1	Enoxaparin (Lovenox)FDA LinkGeneric 03/2003
1	Platelet Membrane GlycoproteinsIBA 12/2001
1	Human Platelet AntigensIBA 12/2001
1	AntigensIBA 11/2001
1	Monoclonal AntibodiesIBA 11/2001
1	BAT monoclonal antibodyIBA 11/2001
1	Immunoglobulin G (IgG)IBA 05/2001
1	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 01/2001
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2000
1	S-nitroso-AR545CIBA 11/2000
1	Oxidoreductases (Dehydrogenase)IBA 06/2000
1	5,10-methylenetetrahydrofolic acidIBA 06/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2000

Therapy/Procedure

1	Microspheres (Microsphere) 03/2013
1	Organ Transplantation 09/2004
1	Stem Cell Transplantation 09/2004
1	Injections 11/2001
1	Immunotherapy 11/2001
1	Therapeutics 11/2000